Research Topics: Tobacco Products

Grant Funding

Program Announcements

The National Cancer Institute currently has two active program announcements (using R01 and R21 mechanisms) encouraging funding applications on tobacco products. The purpose of these funding opportunities is to stimulate multidisciplinary research on potential reduced-exposure tobacco products, both smoked and smokeless, through the interplay of basic, biological, behavioral, surveillance, and epidemiology research. For more information and instructions on applying, please click on the links below.

Testing Tobacco Products Promoted to Reduce Harm (RO1) PA-07-174
Testing Tobacco Products Promoted to Reduce Harm (R21) PA-06-361

New Funding Opportunity Announcements

The National Cancer Institute (NCI) and the National Institute of Dental and Craniofacial Research (NIDCR) encourage the submission of research grant applications from scientists who propose to study the factors that mediate initiation, use, and cessation of smokeless tobacco, to understand the relationship of smokeless tobacco with other tobacco products, and to develop methods for studying smokeless tobacco products and related behaviors in humans.

Measures and Determinants of Smokeless Tobacco Use, Prevention, and Cessation (R01)
RFA-CA-08-024

Measures and Determinants of Smokeless Tobacco Use, Prevention, and Cessation (R21)
RFA-CA-08-025

Currently Funded PREPs Grants

The following grants related to studying tobacco products are currently being funded by the National Cancer Institute.

This list contains grants carried over from prior fiscal years and new grants awarded in the current fiscal year.

** Includes all publications listed in PubMed authored by the Principal Investigator and supported by the specified grant. Please note that not all grants have publications listed in PubMed, and the listing of publications in PubMed may not be complete.